Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

Combining DPCP and anthralin helps regrow hair in some alopecia areata patients.

Demodicosis should be considered in cats with facial skin issues exposed to inhalant glucocorticoids.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

DPCP can help regrow hair in some people with severe alopecia.

A strict gluten-free diet can improve liver issues in celiac disease.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

The higher dose supplement was more effective in treating female hair loss.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Taking five small dutasteride capsules is the same as taking one larger capsule.

Dutasteride helps reduce heavy drinking, especially for those who drink to cope.

Methotrexate-loaded formulations showed promise for psoriasis treatment but need careful evaluation.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Lithocholic acid helps hair growth and regeneration in alopecia by activating vitamin D receptors.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Long-term glucocorticoid use can cause skin problems like easy bruising and poor wound healing, especially at higher doses.